Sky-High Prices For Orphan Drugs Slam American Families And Insurers
Orphan drugs for rare diseases have helped or saved hundreds of thousands of patients like 2-year-old Luke Whitbeck, but families and insurers are picking up the astronomical cost.
Drugmakers Manipulate Orphan Drug Rules To Create Prized Monopolies
Drugmakers have brought almost 450 orphan drugs to market and collected rich incentives but nearly a third of those products aren’t new or were repurposed multiple times, an investigation shows.
Top Price Contributor Allegedly Leaned On Employees To Support PAC
President-elect Donald Trump’s Cabinet pick Tom Price “assisted” a company and campaign donor who tapped executives with an urgent request to donate.
Trump’s HHS Nominee Got A Sweetheart Deal From A Foreign Biotech Firm
Price and another influential GOP congressman got a discounted deal as an Australian firm seeking federal approval sought “sophisticated U.S. investors.”
Trump’s Health Secretary Nominee Sought Special Treatment for Industry Donors
Rep. Tom Price advocated on everything from a sperm test to a hot pepper ingredient on behalf of medical interests that included campaign donors.
Victims Seek Payments As ‘Dr. Death’ Declares Innocence
While hundreds of his former patients submit claims for restitution, a Detroit cancer doctor convicted of making millions by purposefully poisoning them with drugs they didn’t need vows to prove his innocence.
